Searched for
RECIPHARM
Fosun taps big buyout funds for Gland PharmaBuyout firms Advent International, Baring Private Equity Asia (now owned by EQT), Bain Capital, Blackstone, Carlyle and KKR are among those...- Moderna plans mix of COVID-19 vaccine doses with new Lonza dealIt has agreed a deal with Swiss-based drugmaker Lonza which said a new drug substance production line in Geleen, Netherlands, will have cap...
- FIPB clears 6 FDI proposals worth Rs 1,187 croreWith growth in FDI in important sectors like services and manufacturing, overall foreign inflows in the country rose by 30 per cent to $21....
- FIPB clears 6 FDI proposals worth Rs 1,200 croreSome of the proposals which were deferred were those of Crest Premedia Solutions Pvt Ltd, You Broadband India and Scientific Publishing Ser...
- FIPB clears 5 FDI proposals worth Rs 6,050 crore, Cadila gets nodCadila will infuse equity of up to Rs 5,000 crore through issue of shares to QIBs through Qualified Institutional Placement for expansion.
- Swedish firm Recipharm buys majority stake in Nitin Lifesciences for Rs 671 croreSwedish contract drug manufacturing firm Recipharm has acquired a 74% stake in Nitin Lifesciences, a privately held sterile injectables man...
- Recipharm to take majority stake in Nitin Life for Rs 671 croreThe Sweden-based drug firm Recipharm has entered into an agreement to acquire a majority stake in Nitin Lifesciences Ltd.
Load More